|
 Moderna said on Tuesday it had received a report from the California
Department of Public Health that several people at a center in San
Diego were treated for possible allergic reactions after vaccination
from one lot of its COVID-19 vaccine.
The state health department held discussions with various U.S.
authorities, including the U.S. Food and Drug Administration and the
U.S. Centers for Disease Control and Prevention, and found no
scientific basis to continue the pause, state epidemiologist Dr.
Erica Pan said in a statement.
Moderna confirmed the vaccine would continue to be administered in
California when contacted by Reuters.
[to top of second column] |
 Moderna has said it is unaware
of comparable adverse cases from other
vaccination centers which may have administered
vaccines from the same batch as the one in the
San Diego centre, or from other batches.
"These findings should continue to give
Californians confidence that vaccines are safe
and effective," Pan added.
(Reporting by Bhargav Acharya and Sabahatjahan
Contractor in Bengaluru; Editing by Ana Nicolaci
da Costa)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |
